Stay updated on Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new revision entry (v3.4.2) and removed an older notice about government funding/operating status (v3.4.1) from the history page.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding notice banner was added and the page revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI updates on the history page introduce a glossary display, color-coded additions and deletions, and an updated revision label (for example Revision: v3.4.0).SummaryDifference0.6%

- Check35 days agoChange DetectedThe Version History shows a new Revision v3.3.4 added and Revision v3.3.3 removed, reflecting administrative updates to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedFooter updates show the site revision updated to v3.3.3 and the HHS Vulnerability Disclosure link removed, which are administrative UI changes not affecting the trial record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page history adds a new entry for Revision v3.3.2 and removes Revision v3.3.1, reflecting a small metadata update to the version log.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab IV vs SC with Platinum Doublet Chemo in NSCLC Clinical Trial page.